Forde, P. M., Spicer, J., Provencio, M., Mitsudomi, T., Awad, M. M., Wang, C., Lu, S., Felip, E., Broderick, S., Swanson, S., Brahmer, J. R., Kerr, K., Ciuleanu, T., Tanaka, F., Saylors, G. B., Chen, K., Wang, L., Duong, Q., Girard, N. (2025). Overall survival with neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) in patients with resectable NSCLC in CheckMate 816.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba8000